Publications
We introduce books, articles and other materials authored or co-authored by, and interviews with, ABE & PARTNERS attorneys.
-
"The Broad Institute’s CRISPR-Cas9 patents"
Source : LSPN Connect- Article
- IP Disputes
- Life Science and Health Care
-
"The Broad Institute’s CRISPR-Cas9 patents"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"How was Japanese litigation reformed?"
Source : Managing Intellectual Property (WINTER 2020)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"How was Japanese patent litigation reformed"
- Newsletter
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Why reverse payment is unlikely to arise in Japan?"
Source : Fair Trade magazine (November 2020)- Article
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"Inventor of anti-PD-L1 antibody patent"
Source : LSPN Connect- Article
- IP Disputes
- Life Science and Health Care
-
"Inventor of anti-PD-L1 antibody patent"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"Fair value calculation of SEPs for multi-component products"
Source : Managing Intellectual Property(WINTER 2020)- Article
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Fair value calculation of SEPs for multi-component products"
- Newsletter
- IP Disputes
- IP Transactions
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Japan implements new IP mediation proceedings"
Source : Managing Intellectual Property Magazine(Online)- Article
- IP Disputes
-
"New IP Mediation Proceedings"
- Newsletter
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Refunding your deposit in a foreign bank"
- Newsletter
- Cross-Border Transactions
-
"Antibodies: Should they be defined by function or sequence?"
Source : Managing Intellectual Property Magazine(Online)- Article
- IP Disputes
- Life Science and Health Care
-
"Antibodies: Should they be defined by function or sequence?"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"Japan suffers from trade secret infringement"
- Newsletter
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Japan suffers from trade secret infringement"
Source : Managing Intellectual Property Magazine(Spring 2020)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Depriving others of their intellectual property"
Source : Managing Intellectual Property Magazine(Online)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
- International Disputes
- Cross-Border Transactions
- Antitrust/Competition
-
"Depriving others of their intellectual property"
- Newsletter
- IP Disputes
- IP Transactions
- Life Science and Health Care
- IT and Telecommunications
- Cross-Border Transactions
- Antitrust/Competition
-
"Struggle of Gods on unexpected and remarkable effect"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"Battle of judges on unexpected and remarkable effect"
Source : Managing Intellectual Property Magazine (November/December 2019)- Article
- IP Disputes
- Life Science and Health Care
-
"Inspectoin System: Sacred Sword or Rusty Sword?"
- Newsletter
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Inspectoin System: Sacred Sword or Rusty Sword?"
Source : Managing Intellectual Property Magazine (Online)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Rethinking pay for delay"
Source : AIPPI Congress News- News
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"JFTC's attitude towards Reverse Payment"
- Newsletter
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"JFTC’s attitude towards Reverse Payment"
Source : Managing Intellectual Property Magazine (September/October 2019)- Article
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"How is evidence collection and trade secret protection managed during litigation?"
Source : Managing Intellectual Property magazine(Japanese Buyer's Guide 2019)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Analysing the first generic drug cartel case"
Source : Managing Intellectual Property Magazine(July/August 2019)- Article
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"Analyzing the first generic drug cartel case"
- Newsletter
- IP Disputes
- Life Science and Health Care
- Antitrust/Competition
-
"IP High Court finds free riding and dilution by GUZZILLA trademark"
- Newsletter
- IP Disputes
-
"IP High Court finds free riding and dilution by GUZZILLA trademark"
Source : Managing Intellectual Property(May/June 2019)- Article
- IP Disputes
-
"Court addresses foreign clinical trial periods and patent term extension"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"Court addresses foreign clinical trial periods and patent term extension"
Source : Managing Intellectual Property(February 2019)- Article
- IP Disputes
- Life Science and Health Care
-
"Analysing the PD-1 antibody patent litigation"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"Analysing the PD-1 antibody patent litigation"
Source : Managing Intellectual Property Magazine (November 2018)- Article
- IP Disputes
- Life Science and Health Care
-
"Medical Law Dictionary"
Source : co-author, Shinzansha- Book
- Life Science and Health Care
-
"Examining the first biosimilar patent litigation"
Source : Managing Intellectual Property Magazine (October 2018)- Article
- IP Disputes
- Life Science and Health Care
-
"Examining the first biosimilar patent litigation"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"The evolving landscape of the Japanese IP system"
Source : IPPro誌- Interview
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"WHAT IS THE STANCE ON PLAIN PACKAGING ACROSS ASIA?"
Source : Managing Intellectual Property magazine- Interview
- Life Science and Health Care
-
"Examining proposed amendments to evidence collection procedures"
- Newsletter
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"Examining proposed amendments to evidence collection procedures"
Source : Managing Intellectual Property Magazine (September 2018)- Article
- IP Disputes
- Life Science and Health Care
- IT and Telecommunications
-
"How to cope with unfair license agreements"
Source : Intellectual Property Management magazine (July 2018)- Article
- IP Transactions
- Cross-Border Transactions
-
"PRACTITIONERS DOUBTFUL ABOUT PRACTICAL APPLICATION OF JAPAN SEP GUIDELINES"
Source : Managing Intellectual Property magazine- Interview
- IT and Telecommunications
-
"IP High Court affirms validity of crestor patent"
Source : Managing Intellectual Property Magazine (Mid Year 2018)- Article
- IP Disputes
- Life Science and Health Care
-
"IP High Court affirms validity of crestor patent"
- Newsletter
- IP Disputes
- Life Science and Health Care
-
"Patent infringement when a product changes after manufacturing"
Source : Managing Intellectual Property magazine (May 2018)- Article
- IP Disputes
-
"Patent infringement when a product changes after manufacturing"
- Newsletter
- IP Disputes
-
"Points in M&A legal due diligence where a target company has overseas subsidiaries"
- Newsletter
- M&A
-
"First preliminary injunction in a store appearance case"
Source : Managing Intellectual Property magazine(April 2018)- Article
- IP Disputes
-
"First preliminary injunction in a store appearance case"
- Newsletter
- IP Disputes
